Last month, news leaked that the Angels’ Josh Hamilton had self-reported using a recreational drug, despite the fact that possible violations of the Joint Drug Agreement (JDA) are supposed to be kept confidential. Friday, after news broke that an arbitrator had ruled that Hamilton had not violated the JDA, the Angels issued a statement:
The Angels have serious concerns about Josh’s conduct, health and behavior and we are disappointed that he has broken an important commitment which he made to himself, his family, his teammates and our fans. We are going to do everything possible to assure he receives proper help for himself and for the well-being of his family.
The JDA is supposed to assure the anonymity of the process, something that Hamilton did not get the benefit of. It also speaks to problems with the JDA’s treatment of those in recovery from addiction as opposed to those caught using Performance Enhancing Drugs (PEDs). The Commissioner’s Office wants to re-examine the way cases like Hamilton are handled in the future and according to HardBallTalk, both of the owners’ representatives on the board that debated Hamilton’s fate felt that he violated the JDA.